Regulatory Comment Letter

Comments on Sec. 301 Product Exclusions Related to COVID-19

Regulatory Comment Letter

Comments on Sec. 301 Product Exclusions Related to COVID-19

RILA urges the Administration to extend the Section 301 tariff exclusions on essential medical items as tariffs on COVID-related products will harm American businesses, workers, and consumers during an unparalleled crisis.